Investors sold shares of Johnson & Johnson (NYSE:JNJ) on strength during trading on Tuesday. $165.81 million flowed into the stock on the tick-up and $393.20 million flowed out of the stock on the tick-down, for a money net flow of $227.39 million out of the stock. Of all companies tracked, Johnson & Johnson had the 0th highest net out-flow for the day. Johnson & Johnson traded up $1.10 for the day and closed at $146.86

Several research firms recently issued reports on JNJ. Wells Fargo & Co reaffirmed an “outperform” rating and issued a $160.00 price target (up from $155.00) on shares of Johnson & Johnson in a report on Friday, January 12th. Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $150.89 price target on the stock in a report on Thursday, January 11th. Royal Bank of Canada reaffirmed a “buy” rating on shares of Johnson & Johnson in a report on Tuesday, January 9th. JPMorgan Chase & Co. cut shares of Johnson & Johnson from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 2nd. Finally, BMO Capital Markets increased their target price on shares of Johnson & Johnson to $161.00 and gave the stock an “outperform” rating in a report on Tuesday, December 12th. Four analysts have rated the stock with a sell rating, seven have issued a hold rating and eleven have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $145.94.

The company has a market capitalization of $394,860.00, a price-to-earnings ratio of 25.52, a price-to-earnings-growth ratio of 2.77 and a beta of 0.80. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.32 and a quick ratio of 1.02.

Johnson & Johnson (NYSE:JNJ) last released its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The business had revenue of $19.65 billion for the quarter, compared to analysts’ expectations of $19.29 billion. During the same quarter last year, the company earned $1.68 EPS. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. analysts forecast that Johnson & Johnson will post 7.28 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be issued a $0.84 dividend. The ex-dividend date is Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.29%. Johnson & Johnson’s dividend payout ratio (DPR) is presently 58.33%.

Several hedge funds have recently added to or reduced their stakes in JNJ. Harding Loevner LP bought a new position in Johnson & Johnson in the 2nd quarter valued at about $106,000. Mitsubishi UFJ Securities Holdings Co. Ltd. grew its position in Johnson & Johnson by 29.9% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 870 shares of the company’s stock valued at $115,000 after buying an additional 200 shares in the last quarter. Lenox Wealth Advisors Inc. grew its position in Johnson & Johnson by 0.6% in the 2nd quarter. Lenox Wealth Advisors Inc. now owns 876 shares of the company’s stock valued at $116,000 after buying an additional 5 shares in the last quarter. IHT Wealth Management LLC grew its position in Johnson & Johnson by 46.4% in the 2nd quarter. IHT Wealth Management LLC now owns 10,942 shares of the company’s stock valued at $122,000 after buying an additional 3,467 shares in the last quarter. Finally, Mountain Capital Investment Advisors Inc bought a new position in Johnson & Johnson in the 2nd quarter valued at about $124,000. 65.71% of the stock is currently owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This news story was first published by Watch List News and is the property of of Watch List News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.watchlistnews.com/investors-sell-shares-of-johnson-johnson-jnj-on-strength-jnj/1812180.html.

About Johnson & Johnson

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.